[Retracted] CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway

Table 1

Clinicopathological parameters of patients in low-CD73 expression and high-CD73 expression groups.

Terms	Cases	CD73 expression ()
		Low	High	value
Sex
Male ()	53	24	29	0.687
Female ()	61	31	30	0.087
Age (years)
< medium (58)	54	26	28	0.611
≥ medium (58)	60	29	31	0.956
classification
	54	34	20	0.037
	60	21	39	0.015
Clinical stage
Stage I	43	28	15	0.387
Stage II-IV	71	27	44	0.034
Primary tumor size
	49	31	18	0.028
	65	24	41	0.018